Pentobarbital will reduce the extent or influence of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers may lead to decreased serum concentrations and loss of antimalarial efficacy pentobarbital will lower the level or result of verapamil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warn... https://agnesc962jkk0.blog4youth.com/profile